Author: Gerald Ng

cropped Circle

Gerald Ng is a previous editor for Medical Channel Asia. Writing has always been his first love and he has more than a decade of journalism experience after falling in love with reading the newspapers daily growing up in Singapore. His works and interviews have appeared in various media publications including Yahoo!, Straits Times and Channel NewsAsia.

The World Health Organisation (WHO) recently revealed alarming findings about using baby and talcum powder. According to their latest study, the use of these products may increase the risk of cancer in children, sparking concern among parents and the public. Subsequently, Indonesia’s Minister of Health, Budi Gunadi Sadikin, has responded. He is taking the findings seriously and will consider action related to talcum powder. Cancer Risk from Talcum Powder A global WHO study found that exposure to talc, an active ingredient commonly used in cosmetics such as baby powder and loose powder, may increase the risk of cancer in children.…

Read More

Hydrolysed collagen, a popular supplement, is touted for its benefits to skin, joints, and overall health. But does it really work? This article delves into the medical perspective on hydrolysed collagen, examining its efficacy and potential health benefits based on scientific evidence.

Read More

The Department of Health-Center for Health Development in Bicol (DOH CHD-5) announced a 92% treatment success rate for tuberculosis (TB) cases for Q1 2024. This achievement was highlighted during the “Kapihan sa Bagong Pilipinas” briefing held at the Bicol Medical Center in Naga City. This success is indicative of the region’s robust health initiatives and effective implementation of TB treatment protocols. 

Read More
Roche announced today that Tecentriq® SC (atezolizumab) has been approved by the Singapore Health Sciences Authority (HSA) for all indications in which the intravenous (IV) formulation of Tecentriq has been previously approved, including certain types of lung, breast and liver cancer.4 Tecentriq SC is Roche’s fourth subcutaneous cancer therapy,5-7 and the world’s first injectable anti-PD-(L)1 cancer immunotherapy.

Log In or Register as a healthcare professional to read the full article.

Read More

The National University Hospital (NUH) has launched the National University Centre for Trauma. This centre focuses on comprehensive trauma care and outreach to vulnerable groups, including children, older adults, and migrant workers. The initiative aims to enhance safety and prevent trauma across Singapore.

Read More

Singapore is set to roll out measures to address device usage in the coming months as electronic devices and social media increasingly become integral parts of daily life. Health Minister Ong Ye Kung and Minister for Social and Family Development Masagos Zulkifli announced this initiative in separate Facebook posts on June 21, highlighting the need for decisive and effective measures to manage screen time, particularly among the youth.

Read More

The weight-loss drug Ozempic is well-known for its effectiveness in managing type 2 diabetes and aiding significant weight loss. Additionally, it has recently been linked to unexpected pregnancies and new health benefits. Several women reported surprise pregnancies after using the drug. Concurrently, recent studies also suggest Ozempic could reduce the risk of kidney disease progression in diabetic patients.

Read More